Renhuang Pharmaceuticals will launch Schisandra Tablets, a natural anti-depressant, in July. The company expects the new product to generate revenues of 3 million RMB ($440,000) in fiscal year 2010 and 10 million RMB ($1.5 million) in 2011. Schisandra, also known as magnolia vine, is a TCM used to treat a variety of ailments, including neurasthenia. More details...

Stock Symbol: (OTCPK: RHGP)